Biofeedback is a non-invasive rehabilitative therapy that measures biological information and provides feedback to the patient (or therapist) to increase awareness and control over biological processes (Sturma et al., 2018). EMG measures the myoelectric activity of muscles and converts this data into visual and or auditory information (Sturma et al., 2018). Several studies have addressed the use of augmented feedback, such as biofeedback, with spinal cord injured populations. Van Dijik et al. (2005) conducted a systematic review of RCTs analyzing the effect of augmented feedback on motor function of the upper extremity in SCI patients. Much of the information about augmented feedback comes from motor learning literature where it has been noted that feedback combined with task practice enhances motor skill learning (Newell 1991; Schmidt & Lee 1999). There are two types of performance-related information or feedback. The first type of feedback is task intrinsic (inherent feedback). It involves sensory-perceptual information and is a natural part of performing a skill. The second type of feedback is augmented feedback (information-based extrinsic or artificial feedback). Augmented feedback refers to enhancing task intrinsic feedback with an external source (Magill 2001; Schmidt & Lee 1999), such as a therapist or device (biofeedback or timer) (van Dijik et al., 2005). It has been suggested that augmented feedback may have practical implications for rehabilitation therapy since re-acquisition of motor skills is an important part of functional motor recovery (Jarus 1994; Jarus & Ratzon 2005; Kilduski & Rice 2003; Winstein 1991).
The ability to use intrinsic feedback to guide performance is impaired in patients with cognitive and perceptual deficits (Flnn & Radomski 2002). In persons who are compromised by sensory impairments, augmented feedback is important (Sabari 2001).
The methodological details and results of three studies evaluating EMG biofeedback for upper extremity motor rehabilitation in SCI patients are presented in Table 9.